Noom to offer GLP-1 drug through new weight loss program

Noom to offer GLP-1 drug through new weight loss program

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149.  The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk’s blockbuster obesity and diabetes drugs Wegovy and Ozempic. Noom has offered weight loss programs for years, … Read more

Jim Cramer’s top 10 things to watch in the stock market Thursday

Jim Cramer’s top 10 things to watch in the stock market Thursday

My top 10 things to watch Thursday, July 11 The S & P 500 and Nasdaq , both on seven-session winning streaks, were looking lower after more records. The June consumer price index year over year came in around its lowest inflation level in more than three years. Stock futures were initially higher on the … Read more

Jim Cramer on Hims & Hers Health stock

Jim Cramer on Hims & Hers Health stock

CNBC’s Jim Cramer on Wednesday gave his take on Hims & Hers Health, a digital platform that offers telehealth services, particularly for sexual health, mental health, weight loss and skin care. Hims & Hers also provides direct-to-consumer treatments for conditions like erectile dysfunction and hair loss. Cramer suggested it might be worth starting a position … Read more

Digital health companies are launching programs around GLP-1s

Digital health companies are launching programs around GLP-1s

Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice as effective — is expected to expire by the decade’s end. Michael Siluk | UCG | Getty Images For Gray Beard, a kindergarten teacher in Charlotte, North Carolina, losing weight had … Read more

Hims & Hers weight loss adds compounded GLP-1 injections

Jim Cramer on Hims & Hers Health stock

Products of Hims & Hers displayed. Hims & Hers Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 … Read more

Hims & Hers (HIMS) Q4 earnings report

Hims & Hers (HIMS) Q4 earnings report

The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, January 21, 2021. Carlo Allegri | Reuters Hims & Hers Health, the online provider of treatments for erectile dysfunction and hair loss, had its best … Read more